ClinicalTrials.Veeva
Menu

Find clinical trials for Heart Disease in Valencia, VC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Heart Diseases
Cardiovascular Diseases
Heart Failure
Coronary Artery Disease
Myocardial Ischemia
Aortic Valve Stenosis
Heart Valve Diseases

Heart Disease trials near Valencia, VC, ESP:

Transition to KPL-387 Monotherapy Dosing & Administration Study

The primary objective of this study is to characterize the efficacy and safety of dosing regimens used to transition from prior pericarditis therapie...

Enrolling
Heart Diseases
Pericarditis
Drug: KPL-387

Phase 2

Kiniksa Pharmaceuticals International, plc

Valencia, Spain and 40 other locations

The purpose of this study is to establish the safety and effectiveness of pulsed field ablation as a first-line ablation treatment for subjects with...

Active, not recruiting
Persistent Atrial Fibrillation
Device: FARAPULSE™ Pulsed Field Ablation (PFA) System
Drug: Anti-Arrhythmic Drug (AAD): Flecainide, Sotalol, Propafenone, Dofetilide, and Dronedarone
Boston Scientific
Boston Scientific

Valencia, Spain and 60 other locations

tomography (OCT) findings indicative of vulnerable plaque, in patients with ST-elevation myocardial infarction (STEMI) and multivessel disease...

Active, not recruiting
Ischemic Heart Disease
Coronary Artery Disease
Other: FFR>0.80+ OCT with findings indicative of vulnerable plaque
Fundación EPIC

Valencia, Spain and 49 other locations

with placebo in participants with atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Participation...

Enrolling
Chronic Kidney Disease
Atherosclerosis Cardiovascular Disease
Drug: Orforglipron
Drug: Placebo

Phase 3

Lilly
Lilly

Valencia, Spain and 560 other locations

The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications o...

Active, not recruiting
Atherosclerotic Cardiovascular Disease (ASCVD)
Chronic Kidney Disease (CKD)
Drug: Retatrutide
Drug: Placebo

Phase 3

Lilly
Lilly

Valencia, Spain and 762 other locations

in your blood. People with high Lp(a) have a higher risk for heart disease. The main purpose of the study is to investigate how lep...

Enrolling
Cardiovascular Diseases
Lipoprotein(a)
Drug: Lepodisiran
Drug: Placebo

Phase 3

Lilly
Lilly

Valencia, Spain and 57 other locations

This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with cardio...

Active, not recruiting
Cardiovascular Disease
Drug: Cagrilintide
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Valencia, Spain and 638 other locations

population with better kidney function, demonstrated that the efficacy of the SGLT2 inhibitor dapagliflozin in reducing cardiovascular, heart...

Invitation-only
Heart Failure
Kidney Disease, Chronic
Drug: Dapagliflozin 10 mg/day (oral)
Drug: Placebo

Phase 3

University Medical Center Groningen (UMCG)

Valencia, Spain and 102 other locations

in participants with type 2 diabetes who are at higher risk of heart and blood vessel problems and are already taking 1 to 3 diabetes medica...

Enrolling
Cardiovascular Risk
Type 2 Diabetes
Drug: Zenagamtide
Drug: Insulin glargine U-100

Phase 3

Novo Nordisk
Novo Nordisk

Valencia, Spain and 329 other locations

of Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) in the setting of (1) solid organ transplant (SOT) ...

Enrolling
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
Allogeneic Hematopoietic Cell Transplant
Biological: tabelecleucel

Phase 3

Pierre Fabre
Pierre Fabre

Valencia, Valencia, Spain and 70 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems